Turtle Beach Corp  

(Public, NASDAQ:HEAR)   Watch this stock  
Find more results for William E. Keitel�
-0.02 (-0.33%)
Real-time:   11:07AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 6.87 - 7.05
52 week 6.54 - 16.70
Open 7.00
Vol / Avg. 10,827.00/112,810.00
Mkt cap 293.49M
P/E 162.56
Div/yield     -
EPS 0.04
Shares 41.95M
Beta 1.20
Inst. own 13%
Aug 11, 2014
Q2 2014 Turtle Beach Corp Earnings Call
Aug 11, 2014
Q2 2014 Turtle Beach Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -7.59% -3.45%
Operating margin -11.81% 0.90%
EBITD margin - 3.89%
Return on average assets -6.58% -9.37%
Return on average equity -34.96% -
Employees 14 -
CDP Score - -


United States - Map
+1-914-3452255 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Turtle Beach Corp, formerly Parametric Sound Corporation, is a technology company focused on delivering audio solutions through its HyperSound (HSS(r)) technology platform, which consists of the practical application of parametric acoustic technology for generating sound along a directional ultrasonic column. In addition to its commercial product business, the Company is targeting its technology for new uses in consumer markets including computers, video gaming, televisions and home audio along with other commercial markets including casino gaming and cinema. The Company is also researching and developing health applications for persons with hearing loss. The Company's principal markets for its products are North America, Europe and Asia. In October 2012, the Company formed HyperSound Health, Inc. (HHI) as wholly owned subsidiary. In January 2014, the Company completed its merger with privately-held Turtle Beach.

Officers and directors

Juergen Stark President, Chief Executive Officer, Director
Bio & Compensation  - Reuters
John Hanson Chief Financial Officer, Treasurer, Secretary
Bio & Compensation  - Reuters
Laureen DeBuono Director
Bio & Compensation  - Reuters
Ronald Doornink Director
Bio & Compensation  - Reuters
Ken Fox Director
Bio & Compensation  - Reuters
William E. Keitel Director
Bio & Compensation  - Reuters
Andrew L. Wolfe Ph.D. Independent Director
Age: 49
Bio & Compensation  - Reuters